Inorbvict Healthcare India Pvt Limited

Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer.^[3]Specifically it is used for breast cancer that is HER2 receptor positive.^[3] It may be used by itself or together with other chemotherapy medication.^[3] Trastuzumab is given by slow injection into a vein and injection just under the skin.^[3][4]

Common side effects include fever, infection, cough, headache, trouble sleeping, and rash.^[3] Other severe side effects include heart failure, allergic reactions, and lung disease.^[3] Use during pregnancy may harm the baby.^[1] Trastuzumab works by binding to the HER2 receptor and slowing down cell duplication.^[3]

Trastuzumab was approved for medical use in the United States in 1998.^[3] It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system.^[5] The wholesale price in the developing world is between US$1,800 and US$1,955 per 440 mg vial.^[6] In the United Kingdom a 150 mg vial costs the NHS £407.00.^[4